← Back to catalogue

VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364) +1 more model

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K230600Ref 8010419-01Model VERITON CT

by Spectrum Dynamics Medical ltd

Identity

Trade Name
VERITON CT 316 EUDAMED
VERITON CT FDA UDI
Generic Name
SPECT/CT system FDA UDI
Device Name
VERITON CT EUDAMED
Single Photon Emission Computed Tomography System combined with a Computed Tomography (CT) system for x-ray imaging. FDA UDI
Model / Reference
VERITON CT EUDAMED
8010419-01 EUDAMED
VERITON CT 316 FDA UDI
Description
Single Photon Emission Computed Tomography System combined with a Computed Tomography (CT) system for x-ray imaging. FDA UDI

Identifiers

Catalog Number
8010419-01 FDA UDI
Primary DI / UDI-DI
07290108670226 EUDAMEDFDA UDI
Basic UDI-DI
729010867VERITONCT22 EUDAMED
Direct Marketing DI
07290108670226 EUDAMED
510(k) Number
K230600 FDA 510(k)FDA UDI
FDA Product Code
KPS FDA 510(k)FDA UDI
JAK FDA UDI
EMDN Code
Z11020201 CT/GAMMA CAMERA SYSTEMS EUDAMED
GMDN Term
SPECT/CT system FDA UDI

Classification

Device Class
Class IIb EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 892.1200 FDA 510(k)
Regulation Number
892.1200 FDA 510(k)FDA UDI
892.1750 FDA UDI
Market of Registration
Spain EUDAMED
Advisory Committee
Radiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

The Veriton CT 300 and 400 Series are hybrid Digital Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) systems designed for simultaneous functional and anatomical imaging. These devices combine nuclear medicine imaging with CT to provide precise localization and characterization of radiotracer uptake, improving diagnostic accuracy for conditions such as oncology, cardiology, and neurology.

Used in radiology departments, these systems are intended for single-patient use and are not reusable. The Veriton CT 300 and 400 Series feature ring-shaped gantries with 12 digital CZT detectors, enabling 360° total body imaging. They comply with FDA 510(k) and MDR regulatory requirements, with clearance under the Radiology advisory committee. Models include the Veriton CT 316/364 (Series 300) and Veriton CT 416/464 (Series 400).

Manufacturer's product page: VERITON Series

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364 ..., VERITON Series - spectrum-dynamics, VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364 ..., PDF VERITON-CT Series - spectrum-dynamics.com

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

FDA Applicant
Spectrum Dynamics Medical, Ltd.

Sources (3)

  • FDA 510(k) K230600 24 fields · synced Sep 18, 2026
  • FDA UDI bf68f3b4-a1ac-46ff-bae0-5141d9d83e5e 35 fields · synced May 27, 2026
  • EUDAMED 9474ce59-02ae-4e84-945d-360270428abb 61 fields · synced Jul 12, 2026